Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?

To: Larry Liebman who wrote (171)	12/8/1998 8:31:00 PM
From: scaram(o)uche	Respond to of 1475

Larry: What can one say about Amerindo? Can one say that they are clever? No. Can one say that they are the biggest screw-ups to ever hit biotech? Well, I've been around the sector since its inception, and I know of no equals (unless it's the guy who used to advise Mr. Dart, the paper cup Dart.... LIPO, then DEPO..... ever wondered how one might turn a million into 50K?). They initiated, IMO, the tough times for biotech during Winter '97. Got out on a limb, and everyone started to short the companies that they owned. It was the beginning of the "true manipulation" of the biotech sector, IMO. >> According to him all OSIP programs are in place. << Well, trust me, that's bull. However, IMO, enough of them are "in place" to present an attractive picture. Yeah, read the Pfizer pipeline update..... they are gah-gah over OSIP. Everyone should look at the Amerindo website. They provide interactive graphs to show their historical performance. It's all there...... they make it very difficult to get back to Fall '96, but it's all there. ;-) Rick